EGFR and non-small cell lung carcinoma: We revealed that JMJD8 plays a significant role in the proliferation, invasion and epithelial-mesenchymal transition of NSCLC cells by interacting with EGFR and enhancing its stability, which in turn promotes PI3K/AKT signaling.